North America Fish Vaccines Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Fish Vaccines Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Fish Vaccines Market – Key Market Dynamics

5.1 Growth Drivers

5.2 Market Opportunities

5.3 Future Trends

5.4 Impact of Drivers and Restraints

6. North America Fish Vaccines Market Regional Analysis

6.1 North America Fish Vaccines Market Overview

6.2 North America Fish Vaccines Market Revenue 2020-2030 (US$ Million)

6.3 North America Fish Vaccines Market Forecast Analysis

7. North America Fish Vaccines Market Analysis – by Vaccine Type

7.1 Inactivated Vaccines

7.1.1 Overview
7.1.2 Inactivated Vaccines: North America Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Live Attenuated Vaccines

7.2.1 Overview
7.2.2 Live Attenuated Vaccines: North America Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Subunit Vaccines

7.3.1 Overview
7.3.2 Subunit Vaccines: North America Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Recombinant Vector Vaccine

7.4.1 Overview
7.4.2 Recombinant Vector Vaccine: North America Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Fish Vaccines Market Analysis – by Application

8.1 Bacterial Infection

8.1.1 Overview
8.1.2 Bacterial Infection: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Viral Infection

8.2.1 Overview
8.2.2 Viral Infection: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Parasitic

8.3.1 Overview
8.3.2 Parasitic: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Fish Vaccines Market Analysis – by Route of Administration

9.1 Injection Vaccine

9.1.1 Overview
9.1.2 Parasitic: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Immersion Vaccine

9.2.1 Overview
9.2.2 Parasitic: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Oral Vaccine

9.3.1 Overview
9.3.2 Parasitic: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Fish Vaccines Market – North America Analysis

10.1 North America

10.1.1 North America Fish Vaccines Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Fish Vaccines Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.1.2 US: North America Fish Vaccines Market Breakdown, by Application
10.1.1.1.3 US: North America Fish Vaccines Market Breakdown, by Route of Administration

10.1.1.2 Canada: North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.2.2 Canada: North America Fish Vaccines Market Breakdown, by Application
10.1.1.2.3 Canada: North America Fish Vaccines Market Breakdown, by Route of Administration

10.1.1.3 Mexico : North America Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.3.2 Mexico : North America Fish Vaccines Market Breakdown, by Application
10.1.1.3.3 Mexico : North America Fish Vaccines Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Fish Vaccines Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Elanco Animal Health Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Hipra SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Merck & Co Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Phibro Animal Health Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Vaxxinova International BV

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Zoetis Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights